Which elderly patients should be considered for anti-hypertensive treatment ? An evidence-based approach : Hypertension in the Elderly.
Meeting of the European Society of Hypertension. Krakow, POL, 1997/06/21.
The evidence-based approach to medical care involves the explicit use of evidence on the magnitude of the effects of interventions to inform diagnostic and treatment decisions.
This article critiques current mainstream guidelines on the management of hypertension in the elderly (aged 60 years and over) and presents an alternative evidence-based approach.
Three major national and international guidelines for the management of hypertension from the United Kingdom (UK), the United States (US) and from a joint World Health Organisation/International Society of Hypertension (WHO/ISH) Working Party were appraised and the evidence on which they were based was reviewed.
The relevant evidence was also assessed to determine the likely magnitude of risks and benefits of anti-hypertensive treatment in older people and an alternative approach to making treatment decisions, based on the New Zealand guidelines for the management of hypertension, is described.
Hypertension management guidelines from the UK, US and WHO/ISH made similar recommendations about which elderly patients should be treated, although there were some ambiguities in their advice.
Treatment recommendations were based primarily on blood pressure levels which were set at about 160 mm Hg systolic and/or 90 mm Hg diastolic. (...)
Mots-clés Pascal : Hypertension artérielle, Antihypertenseur, Analyse coût efficacité, Economie santé, Chimiothérapie, Traitement, Indication, Vieillard, Homme, Appareil circulatoire pathologie
Mots-clés Pascal anglais : Hypertension, Antihypertensive agent, Cost efficiency analysis, Health economy, Chemotherapy, Treatment, Indication, Elderly, Human, Cardiovascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0468872
Code Inist : 002B12B05B. Création : 19/02/1999.